Breather Trainer Versus Pulmonary Rehabilitation on Cardiopulmonary Efficiency

Horus University

Status: Unknown

Conditions: COVID-19; COPD

Treatments: Other: The breather respiratory muscle trainer; Other: interval aerobic training and respiratory training; Other: Diaphragmatic and localized breathing exercises

Study type: Interventional

Funder types: Other

Identifiers

NCT05382780

Eman_Rashad_PhD_2022

Details and patient eligibility

About

The purpose of the study is to determine the difference between The Breather respiratory muscle trainer and pulmonary rehabilitation in patients with COPD post COVID-19.

Full description

The main concern in post COVID-19 patients is the involvement of respiratory system and cardiovascular system which may result in dyspnea, low blood oxygen saturation, and decrease cardiopulmonary efficiency.

In cases of post COVID-19 patients with COPD their state is deconditioned and more critical than normal to be either in the zone of progression or regression or stability as the studies showed that handling of these cases during (3-6 months post-COVID) will prevent these symptoms from becoming permanent.

Enrollment: 80 estimated patients

Sex: All

Ages: 30 to 40 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

1. SPO2 ≥ 93%
2. Their age ranges from 30-40 years old.
3. COPD patients GOLD1 (Mild FEV1≥80% predicted) and GOLD2 (Moderate 50% ≤FEV1<80%predicted) (Manian, 2019)
4. patients diagnosed as post COVID-19 Pneumonia between 3 and 6 Months ago with CT scan and PCR testing.
5. Their body mass index (BMI) ranged from 20 to 29.9kg/m2.
6. Stable medical cases with dyspnea

Exclusion criteria

Patients who will meet one of the following criteria will be excluded from the study:

1. patients with cardiac problems e.g. atrial fibrillation, left bundle-branch block, heart failure.
2. Sever cases of COPD (FEV1/FVC< 50%)
3. Mitral or aortic valvular disease, pericardial effusion.
4. Recent myocardial infarction.

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Double Blind

---

80 participants in 2 patient groups

The breather respiratory muscle trainer group

Experimental group

Description:

40 patients (20 males and 20 females) will receive The breather respiratory muscle trainer for 30 minutes and mild interval aerobic training and respiratory training on treadmill 3 times / week for 12 weeks.

Treatment:

Other: The breather respiratory muscle trainer

Other: interval aerobic training and respiratory training

Diaphragmatic and localized breathing exercises group

Experimental group

Description:

40 patients (20 males and 20 females) will receive diaphragmatic and localized breathing exercises ( especially Middle \& Lower segments) and mild intensity interval aerobic training and respiratory training on treadmill 3 times / week for 12 weeks,

Treatment:

Other: interval aerobic training and respiratory training

Other: Diaphragmatic and localized breathing exercises